Event Brief
Aug 7, 2026 at 8:08 AM ET
WRSs2 vaccine shows 89% effectiveness against shigellosis
By The BriefBrief
Trials of the WRSs2 vaccine reported 89% effectiveness against shigellosis, a major cause of diarrheal deaths.
WHO: WRSs2 vaccine trial teams at Cincinnati Children's Hospital Medical Center and Emory Vaccine Center's Hope Clinic
WHAT: Results published in The Lancet Infectious Diseases reported 89% effectiveness of the WRSs2 vaccine against shigellosis.
WHEN: Reported Aug 7, 2026 at 7:36 AM ET
WHERE: Location not specified
WHY: The vaccine trial results showed high effectiveness at preventing shigellosis.
Reporting from 1 identified publisher for this event.
View all 1 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Houthis’ cross-border attacks signal major battle in Yemen
Houthis
Aug 7, 2026 at 8:11 AM ET
Shakib says he will return if security guaranteed
Shakib Al Hasan
Aug 7, 2026 at 8:11 AM ET
Picnic in the Park honors Grainger cancer survivors
Grainger County
Aug 7, 2026 at 8:00 AM ET
Insurance commissioner candidates split key endorsements
Insurance Commissioner
Aug 7, 2026 at 8:00 AM ET
Page 10478 of 21439
Same format. Every time.
Continue reading — sign in or create a free account with
